Corti, C., Jin, Q., Stever, C., Martin, A. R., Okui, C. H., Ahmad, N., Tung, N. M., Sinclair, N., Faggen, M. G., Sinclair, S., Constantinou, M., Lo, S., Meisel, J. L., Winer, E. P., Curigliano, G., Lin, N. U., Mittendorf, E. A., Tayob, N., Tolaney, S. M., Garrido-Castro, A. C. (2026). Outcomes after recurrence on neoadjuvant chemo-immunotherapy (NCIT) in patients (pts) with high-risk early-stage triple-negative breast cancer (eTNBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.601